Drug Manufacturers—General Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 10 | LLY Eli Lilly and Company Common Stock | 1228.53 USD | -0.58% | +3.16% | +5.40% | +56.74% | 1.16 T USD | ||
| 17 | JNJ Johnson & Johnson Common Stock | 267.12 USD | -0.05% | +5.82% | +14.97% | +71.42% | 643.02 B USD | ||
| 22 | ABBV AbbVie Inc. Common Stock | 254.73 USD | +0.04% | +1.96% | +13.17% | +35.20% | 450.06 B USD | ||
| 39 | MRK Merck & Company, Inc. Common Stock | 126.76 USD | -1.64% | +0.28% | +5.61% | +53.93% | 313.07 B USD | ||
| 43 | NVS Novartis AG | 155.85 USD | -0.74% | +0.72% | +5.86% | +27.39% | 297.39 B USD | ||
| 65 | AMGN Amgen Inc. - Common Stock | 368.67 USD | +0.15% | +2.10% | +5.87% | +23.49% | 198.97 B USD | ||
| 88 | GILD Gilead Sciences, Inc. - Common Stock | 135.76 USD | -0.44% | +7.65% | +5.40% | +20.75% | 168.56 B USD | ||
| 108 | PFE Pfizer, Inc. Common Stock | 24.30 USD | +0.96% | +1.55% | -5.56% | -5.19% | 138.50 B USD | ||
| 133 | BMY Bristol-Myers Squibb Company Common Stock | 57.85 USD | -0.22% | +1.97% | +3.40% | +22.56% | 118.13 B USD | ||
| 136 | GSK GSK plc American Depositary Shares (Each representing two Ordin | 52.87 USD | -0.86% | +3.04% | +4.84% | +20.57% | 114.08 B USD | ||
| 143 | SNY Sanofi - American Depositary Shares | 42.99 USD | +0.02% | +3.57% | -3.28% | -11.76% | 104.85 B USD | ||
| 414 | ONC BeOne Medicines Ltd - American Depositary Shares | 299.29 USD | -3.13% | +2.44% | +11.82% | -5.20% | 33.27 B USD | ||
| 454 | BIIB Biogen Inc. - Common Stock | 199.24 USD | -3.14% | -6.30% | +1.91% | +48.07% | 29.42 B USD | ||
| 1201 | CGON CG Oncology, Inc. - Common stock | 68.67 USD | -0.77% | -2.73% | +23.20% | +57.64% | 6.06 B USD | ||
| 1308 | ORKA Oruka Therapeutics, Inc. - Common Stock | 81.19 USD | -3.92% | -14.35% | +24.91% | +153.16% | 4.90 B USD | ||
| 1329 | MANE Veradermics, Incorporated Common Stock | 116.81 USD | +0.02% | -8.93% | +24.97% | +253.97% | 4.88 B USD | ||
| 1589 | OGN Organon & Co. Common Stock | 13.51 USD | 0.00% | -0.59% | +0.90% | +86.09% | 3.55 B USD | ||
| 1711 | MBX MBX Biosciences, Inc. - Common Stock | 62.34 USD | +0.55% | +9.60% | +110.11% | +372.63% | 2.97 B USD | ||
| 1957 | PVLA Palvella Therapeutics, Inc. - Common Stock | 141.33 USD | -3.00% | +0.21% | +33.08% | +91.37% | 2.03 B USD | ||
| 1966 | GENB Generate Biomedicines, Inc. - Common Stock | 15.66 USD | -3.45% | -5.21% | +22.54% | +4.40% | 2.01 B USD |
Notícias Drug Manufacturers—General Stocks
Truist eleva preço-alvo da Eli Lilly com força do portfólio de incretinas
AstraZeneca e Daiichi Sankyo perto de acordo de preço para Enhertu no Reino Unido
ARK de Cathie Wood vende AMD e compra SpaceX e X-Energy
Ação da Eli Lilly atinge máxima histórica de US$ 1.238,06
Ação da Johnson & Johnson atinge máxima histórica de US$ 264,98
Semnur Pharmaceuticals assina acordo para investimento de US$ 100 milhões
E.U.A. - Ações fecharam o pregão em alta e o Índice Dow Jones Industrial Average avançou 0,30%
Gainers Drug Manufacturers—General Stocks
ERNAW Ernexa Therapeutics Inc. - Warrants | 0.1100 | +94.00% |
MDCXW Medicus Pharma Ltd. - Warrant | 0.7100 | +7.58% |
PTHS Pelthos Therapeutics Inc. Common Stock | 25.96 | +4.42% |
APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 0.76 | +2.70% |
IBO Impact BioMedical, Inc. Common Stock | 0.46 | +2.22% |
PPCB Propanc Biopharma, Inc. - Common Stock | 1.84 | +1.10% |
PFE Pfizer, Inc. Common Stock | 24.30 | +0.96% |
EXOZ eXoZymes Inc. - Common Stock | 7.85 | +0.90% |
Losers Drug Manufacturers—General Stocks
VIVS VivoSim Labs, Inc. - Common Stock | 0.80 | -11.11% |
OSTX OS Therapies Incorporated Common Stock | 1.47 | -8.70% |
EIKN Eikon Therapeutics, Inc. - Common Stock | 10.60 | -8.62% |
DCOY Decoy Therapeutics Inc. - Common Stock | 6.47 | -7.83% |
MDCX Medicus Pharma Ltd. - Common Stock | 0.41 | -6.82% |
QTTB Q32 Bio Inc. - Common Stock | 12.85 | -5.65% |
AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.75 | -4.59% |
SCLX Scilex Holding Company - Common Stock | 9.48 | -4.53% |